Amgen Ventures
As a company formed with venture capital funding more than 25 years ago, they understand the challenges faced by early-stage biotechnology companies. In 2004, they announced the formation of Amgen Ventures, their corporate venture capital fund. With...Founded in 2004
Homepage: http://www.amgen.com/partners/amgen_ventures.html
HQ
91320-1799 One Amgen Center DriveThousand Oaks
USA CA
Phone: (805) 447-1000
Amgen Ventures at CrunchBase
March, 2013
Amgen Ventures invested $8M in Theraclone Sciences as a Series B round
May, 2012
Amgen Ventures invested $16.5M in Sutro Biopharma as a Series C round
April, 2012
Amgen Ventures invested $20M in Miragen Therapeutics as a Series B round
August, 2011
Amgen Ventures invested $30M in Ardelyx as a Series B round
Amgen Ventures invested $2.1M in Oncofactor Corporation as a Series A round
January, 2011
Amgen Ventures invested $4.4M in Acylin Therapeutics as a Series A round
November, 2010
Amgen Ventures invested $36.5M in Sutro Biopharma as a Series C round
September, 2010
Amgen Ventures invested $3.2M in DecImmune Therapeutics as unattributed round
August, 2010
Amgen Ventures invested $32M in TetraLogic Pharmaceuticals as a Series C round
June, 2010
Amgen Ventures invested $40M in Calistoga Pharmaceuticals as a Series C round
March, 2010
Amgen Ventures invested $1.5M in Theraclone Sciences as unattributed round
November, 2009
Amgen Ventures invested $7.5M in Trinity Biosystems as unattributed round
October, 2009
Amgen Ventures invested $32M in Epizyme as a Series B round
June, 2009
Amgen Ventures invested $4M in Miragen Therapeutics as a Series B round
May, 2009
Amgen Ventures invested $30M in Calistoga Pharmaceuticals as a Series B round
August, 2008
Amgen Ventures invested $18.5M in InteKrin as a Series C round
October, 2007
Amgen Ventures invested $30M in Allozyne as a Series B round
June, 2007
Amgen Ventures invested $15.8M in Argolyn Bioscience as a Series A round
March, 2007
Amgen Ventures invested $21M in Calistoga Pharmaceuticals as a Series A round
July, 2006
Amgen Ventures invested $21M in Trinity Biosystems as a Series B round
June, 2006
Amgen Ventures invested $55M in VLST Corporation as a Series B round
May, 2006
Amgen Ventures invested $20M in Viron Therapeutics as a Series A round
Amgen Ventures invested $43.8M in Avidia as a Series C round
December, 2005
Amgen Ventures invested $3.5M in Allozyne as a Series A round
November, 2005
Amgen Ventures invested $26.6M in PTC Therapeutics as unattributed round
May, 2005
Amgen Ventures invested $28.5M in Avidia as a Series B round
2004
Amgen Ventures was founded in 2004